the pharmacokinetics and pharmacodynamics of repeated oral administration of furosemide were studied in patients with chronic renal failure or nephrotic syndrome using three different dosage regimens ( 4 x 40 , 4 x 80 and 4 x 250 mg/d ) .
C0016860
furosemide
C0027726
nephrotic